A long-acting insulin that almost everyone (in the Australian T1 diabetes world anyway) knows of is “Lantus”, even though it was replaced by the identical Optisulin 2 years ago. It took a while to be phased out. A few months prior (back in October 2019) I reported the arrival of “Semglee”. This is marketed by …
Having sourced a bit of Lyumjev from overseas, I’ve been able to “give it a run”. In fact I’ve been using it for almost two months now. My conclusions? As expected, I’m really keen for it to officially arrive in Australia! I’ve been mentioning Lyumjev for many months, but to recap: it’s Lilly’s faster version …
I’ve added an addendum to last month’s “Comparing multiple insulins” article, with some observations about the closed-loop performance once I went back to the “Ultra-Rapid” Fiasp. I’m continually impressed. Even when we throw in a Mexican feast!
For years I used Humalog as my “fast” insulin (before that I used Actrapid!) so when I moved to Fiasp that’s what I had to compare with. I’ve recently experimented with switching back to Humalog to check my settings, and the results were interesting. Including that my no-bolus, no-announce closed-loop system still worked. I have …
People who know me wouldn’t be surprised to hear I’ve been experimenting with an insulin change recently. I started out pumping using Humalog. In 2018 I spent a few months experimenting with Apidra in the hope I could get a faster result (and thus a more-responsive loop). And then when Fiasp finally arrived in Australia …
I have previously written about issues with DIA (“duration of insulin action”) and the values we use in traditional pumps and in loop systems. This is an exploration of some of the recent work on tuning my own loop that’s affected by this. 6 hours? First, let’s look at a visualisation of the “Insulin On …